Citations

Clear

4847 citation(s) found for "Tu, Eric".

Orthostatic myoclonus
Glass, Graham A., Ahlskog, J. Eric , Matsumoto, Joseph Y.

Mayo Clinic

Neurology | March 15, 2007 | Volume: 68 | Issue: 21 | Pages: 1826-1830

10.1212/01.wnl.0000260225.46732.af | PMID 17360964 Get It

Psychometric Properties of the Mattis Dementia Rating Scale
Ivnik, Robert J., Malec, James F. , Kokmen, Emre, Tangalos, Eric G., Petersen, Ronald C. , Smith, Glenn E.

Mayo Clinic

Assessment | March 10, 2007 | Volume: 1 | Issue: 2 | Pages: 123-131

10.1177/1073191194001002002 | PMID 9465142 Get It

This study investigated the psychometric properties of the Mattis Dementia Rating Scale (DRS), including its internal consistency, sensitivity to age and education effects, pattern of change scores, convergent validity and predictive utility. Age and education effects and stability were assessed in a sample of 280 cognitively normal persons over age 55. All other features were assessed in a sample of 274 persons with cognitive impairment, including 221 newly diagnosed dementia patients and 53 patients with mild cognitive impairment. Both samples were drawn from the Mayo Clinic Alzheimer's Disease Patient Registry. Within the normal sample, Pearson correlation coefficients for DRS Total score with age, education and intelligence were all significant, p < .0001; MAYO Full Scale IQ (FSIQ) shared approximately 20% variance with DRS Total score. Internal consistency was greater than .7 for Construction, Conceptualization, Memory, and Total score, greater than .65 for Attention and less than .5 for Initiation and Perseveration. DRS subscales cores for Memory, Attention, and Conceptualization were significantly correlated with appropriate indices from the WAIS-R or Wechsler Memory Scale-Revised, as assessed in the Mayo Older Americans Normative Studies, providing convergent validity for these DRS scales. Importantly, proportional hazards modeling revealed initial DRS Total score to be a significant predictor of longitudinal institutionalization and mortality outcomes.
LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer
Bondar, Olga P., Barnidge, David R. , Klee, Eric W. , Davis, Brian J. , Klee, George G., Davis, Brian J

Mayo Clinic

Clinical Chemistry | February 23, 2007 | Volume: 53 | Issue: 4 | Pages: 673-678

10.1373/clinchem.2006.079681 | PMID 17317883 Get It

AbstractBackground: Zn-α2 glycoprotein (ZAG) is a relatively abundant glycoprotein that has potential as a biomarker for prostate cancer. We present a high-flow liquid chromatography–tandem mass spectrometry (LC-MS/MS) method for measuring serum ZAG concentrations by proteolytic cleavage of the protein and quantification of a unique peptide.Methods: We selected the ZAG tryptic peptide 147EIPAWVPEDPAAQITK162 as the intact protein for quantification and used a stable isotope-labeled synthetic peptide with this sequence as an internal standard. Standards using recombinant ZAG in bovine serum albumin, 50 g/L, and a pilot series of patient sera were denatured, reduced, alkylated, and digested with trypsin. The concentration of ZAG was calculated from a dose–response curve of the ratio of the relative abundance of the ZAG tryptic peptide to internal standard.Results: The limit of detection for ZAG in serum was 0.08 mg/L, and the limit of quantification was 0.32 mg/L with a linear dynamic range of 0.32 to 10.2 mg/L. Replicate digests from pooled sera run during a period of 3 consecutive days showed intraassay imprecision (CV) of 5.0% to 6.3% and interassay imprecision of 4.4% to 5.9%. Mean (SD) ZAG was higher in 25 men with prostate cancer [7.59 (2.45) mg/L] than in 20 men with nonmalignant prostate disease [6.21 (1.65) mg/L, P = 0.037] and 6 healthy men [3.65 (0.71) mg/L, P = 0.0007].Conclusions: This LC-MS/MS assay is reproducible and can be used to evaluate the clinical utility of ZAG as a cancer biomarker.
Effect of referral bias on assessing survival in ALS
Sorenson, Eric J. , Mandrekar, Jayawant N. , Stevens, J. Clarke, Crum, Brian A.

Mayo Clinic

Neurology | February 19, 2007 | Volume: 68 | Issue: 8 | Pages: 600-602

10.1212/01.wnl.0000254501.58158.e7 | PMID 17310031 Get It

The Diagnostic Utility of Midcarpal Anesthetic Injection in the Evaluation of Chronic Wrist Pain
Bell, S. Josh, Hofmeister, Eric P., Moran, Steven L. , Shin, Alexander Y. , Shin, Alexander Y

Mayo Clinic

HAND | January 26, 2007 | Volume: 2 | Issue: 2 | Pages: 39-45

10.1007/s11552-006-9014-2 | PMID 18780061 Get It

The evaluation of chronic wrist pain can be a diagnostic dilemma. Lidocaine injections combined with corticosteroids are often used for both diagnosis and therapy. The purpose of this study was to determine if a midcarpal injection of lidocaine could serve as a diagnostic tool in patients with chronic wrist pain. Specifically, the relationship of pain relief from the injection and improvement of grip strength were compared to the presence of intracarpal pathology as confirmed by wrist arthroscopy. Forty-five patients with chronic wrist pain underwent a midcarpal injection of lidocaine with or without corticosteroids. Forty of the 45 underwent comcomitant steroid injections; a majority of the 40 patients reported relief of pain for two or more weeks. Improvement of pain and improvement of grip strength were determined. Each of these patients subsequently underwent a radiocarpal and midcarpal arthroscopy, and the pathologic findings of arthroscopy were compared to the improvement of pain and grip strength. These data were compared to a cohort of six volunteers without history of wrist pain or trauma that underwent midcarpal injection of lidocaine. Statistical analysis was performed using Reciever-Operator-Characteristic analysis. The average age of patients with chronic pain was 30.3 years, with an average of 9.8 months of wrist pain. The ultimate diagnoses included 35 patients with carpal instability dissociative, two with nondissociative instability, seven with complex instability of the carpus, three with extensor carpi ulnaris tendonitis and one with deQuervain's tenosynovitis. After lidocaine injection, the normal cohort had a mean loss of 2 kg (-5.3%) ( p=0.02) in grip strength, whereas the experimental cohort had a mean improvement in grip strength of 5.73 kg (34.4%). Improvement of pain after injection did not correlate with pathologic arthroscopic findings ( p=0.92). Improvement in grip strength after midcarpal lidocaine injection of 6 kg or 28% had a 73% sensitivity and a 70% specificity ( p=0.02) of having intracarpal pathology at the time of arthroscopy. Of the chronic wrist pain patients, only four had a normal arthroscopy, and the remainder had at least one area of significant pathology attributing to their pain. We conclude that a midcarpal injection of lidocaine can serve as an effective diagnostic tool in the evaluation of the patient with chronic wrist pain. Improvement of grip of 28% with or without relief of pain is highly correlated with intracarpal pathology.
The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer
Goldberg, Richard M. , Rothenberg, Mace L., Benson, Al B. , Blanke, Charles D. , Diasio, Robert B. , Grothey, Axel, Lenz, Heinz‐Josef , Meropol, Neal J. , Ramanathan, Ramesh K., Becerra, Carlos H.R., Wickham, Rita , Armstrong, Delma, Viele, Carol, Cutsem, Eric Van

Mayo Clinic

The Oncologist | January 17, 2007 | Volume: 12 | Issue: 1 | Pages: 38-50

10.1634/theoncologist.12-1-38 | PMID 17227899 Get It

Learning ObjectivesAfter completing this course, the reader should be able to: Discuss recent progress in the treatment of patients with advanced colorectal cancer.Define the continuum-of-care approach and how it may differ from our current approach to the treatment of patients with advanced colorectal cancer.Identify key factors in treatment selection for patients with advanced colorectal cancer.Explain the impact of each active drug in the treatment of advanced colorectal cancer and the impact of treatment with multiple agents over the course of the disease.CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Lipoma of the nasal dorsum: An unusual presentation of a common neoplasm
Pryor, Shepherd G., Orvidas, Laura J. , Moore, Eric J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 9, 2007 | Volume: 136 | Issue: 1 | Pages: 151-152

10.1016/j.otohns.2005.11.029 | PMID 17210358 Get It

IN VIVO LOCATION OF JOINT CENTERS OF THE SHOULDER SYSTEM: GLENO-HUMERAL AND SCAPULO-THORACIC JOINTS BETWEEN TWO POSTURES DESCRIBING THE ARM ELEVATION IN THE PLANE OF SCAPULA USING TECHNIQUES BASED UPON BIPLANAR RADIOGRAPHY
Berthonnaud, Éric , Herzberg, Guillaume , Morrow, Duane A., An, Kai‐Nan, Dimnet, J.

Mayo Clinic

Journal of Mechanics in Medicine and Biology | January 8, 2007 | Volume: 06 | Issue: 04 | Pages: 385-397

10.1142/s0219519406002060 Get It

In biomechanics, the knowledge of accurate location of a joint center is essential because equilibration of the external loads and muscular forces about the joint is performed about this specific point. This paper focuses on the location of centers of gleno-humeral joint and scapulo-thoracic joint in a subject moving their arm in the scapular plane with a magnitude of 120°. Biplanar radiography with successive exposures has been used locating anatomical axes of bones. Geometric models of bones were defined allowing access to bone morphology by superposing model projections onto X-ray imaged bone contours. Functional models were used so as to represent the behavior in motion of shoulder joints. These techniques allowed us to access to results describing the linear and angular relative displacements of the shoulder bones between two different postures. The gleno-humeral and scapulo-thoracic finite joint centers (F H and F S ) are first defined through the location of the corresponding helical axis of motion (HAM) moving the joint from positions occupied in initial and final postures. The gleno-humeral and scapulo-thoracic mean joint centers (M H and M S ) are then calculated using a new technique, which defines that each joint center has the point having the smallest migrations while moving continuously from initial to final postures. This allows for the analysis of the linear and angular clearances, which affect joint center migration. The whole continuous movement has been parsed into several steps to test the stability of the mean joint center throughout the motion.
An acute, life-threatening, hypersensitivity reaction to riluzole
Sorenson, Eric J.

Mayo Clinic

Neurology | December 26, 2006 | Volume: 67 | Issue: 12 | Pages: 2260-2261

10.1212/01.wnl.0000249182.09143.20 | PMID 17190960 Get It

Mayo's Older Americans Normative Studies: Visual Form Discrimination and copy trial of the Rey–Osterrieth Complex Figure
Ivnik, Robert J., Smith, Glenn E. , Ferman, Tanis J. , Petersen, Ronald C. , Tangalos, Eric G., Machulda, Mary M. , Boeve, Bradley F. , Knopman, David S. , Ferman, Tanis J

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | December 21, 2006 | Volume: 29 | Issue: 4 | Pages: 377-384

10.1080/13803390600726803 | PMID 17497561 Get It